Biden Heads to Japan for the G7
Also, global heat to rise over the next five years. Here’s the latest at the end of Wednesday.
Drug Shortages Near an All-Time High, Leading to Rationing
A worrisome scarcity of cancer drugs has heightened concerns about the troubled generic drug industry. Congress and the White House are seeking ways to address widespread supply problems.
U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeutics
The Federal Trade Commission said the deal would enable Amgen to “entrench” the monopoly positions of two Horizon drugs that lack competition.
Some Pharmacies Are Offering Unauthorized Ozempic Alternatives
Regulators are raising concerns about compounded semaglutide.
A U.S. Experiment on Single-Payer Care Just Ended
The system for one disease, Covid, had similarities to “Medicare for all.”
Esto se sabe sobre Opill, la nueva ‘minipíldora’ anticonceptiva
Los asesores de la FDA afirman que los beneficios superan sus riesgos. La agencia decidirá si en pocos meses el anticonceptivo podrá venderse sin receta en Estados Unidos.
What to Know About the New Treatment for Hot Flashes
Veozah, a nonhormonal drug, is effective against a signature symptom of menopause.
Big Pharma Is Avoiding Taxes, and Trump’s Tax Reforms Made It Worse
Tax avoidance is a drug on the market.
FDA Approves New Drug to Treat Hot Flashes
It is the first nonhormonal treatment for the menopause symptom.
Public Health Lessons Learned From the Coronavirus Pandemic
The United States’ struggle to respond to the virus has highlighted the importance of communicating with the public, sharing data and stockpiling vital supplies.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.